Trials / Completed
CompletedNCT04416217
Eosinophilic Esophagitis Steroid Safety Study
Adrenal Suppression in Pediatric Eosinophilic Esophagitis Treated With Topical Steroids - A Multicenter, Prospective, Observational Safety Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will follow pediatric patients with eosinophilic esophagitis who are scheduled to begin topical steroid treatment, from the initiation of treatment longitudinally to determine the safety profile of the drug.
Conditions
Timeline
- Start date
- 2019-10-07
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2020-06-04
- Last updated
- 2025-05-07
Locations
4 sites across 3 countries: Greece, Israel, Italy
Source: ClinicalTrials.gov record NCT04416217. Inclusion in this directory is not an endorsement.